Thermosome raises €4.6m with first financing round and a research grant from the German government
Thermosome announces the closing of its first financing round, raising net proceeds of approximately €1.9 million from funds managed by High-Tech Gründerfonds Management GmbH and Bayern Kapital GmbH, respectively, as well as a group of private investors. This first financing round is substantially enlarged by a recently approved grant from the German Federal Ministry of Education and Research (BMBF) providing additionally €2.7 million over the project duration of 3 years. The proceeds from the first financing round and the grant will be used to move Thermosome’s lead candidate through GMP manufacturing and pre-clinical development into a first clinical study in patients with certain solid tumors. Thermosome envisions to use its novel platform technology to vastly enlarge the therapeutic index and safety window of drugs and reach improved therapeutic outcomes in patients.
- On 6. April 2016